UNSPSC 51173212: Bisacodyl/phospho soda

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173212 Bisacodyl/phospho soda is a Commodity code that captures state and local procurement of specific pharmaceutical products—primarily generic laxatives and bowel-prep medications—though recent solicitations show the code being applied inconsistently across different procurement contexts. State and local governments acquire these products for correctional facilities, public health programs, and cooperative purchasing agreements serving multiple jurisdictions. The issuing bodies include county corrections departments, state health and human services commissions, and multistate cooperative purchasing alliances coordinating procurement across participating state and local agencies. Collin County Community Supervision and Corrections Department and the Texas Health and Human Services Commission appear as active buyers in the recent record.

Geographic activity centers on Texas and the upper Midwest, with Collin County driving recent corrections-focused procurement and Minnesota's multistate cooperative (MMCAP) managing broader pharmaceutical supply agreements for participating state and local facilities. Representative opportunities include Collin County's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated value $600,000, two-year term with three optional renewals), which includes testing supplies and related pharmaceutical services; the Texas Health and Human Services Commission's RFI HHS0017013 (posted March 27, 2026) exploring direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager channels; and MMCAP's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026. The MMCAP procurement emphasizes price competitiveness (75 percent of evaluation score), product availability by May 15, 2026, manufacturer compliance with cGMP and DSCSA standards, and contracted relationships with authorized wholesalers AmerisourceBergen (Cencara), Cardinal Health, and Morris & Dickson.